Abstract: An image forming apparatus includes a mounting unit configured to mount a cartridge including a developing member by moving the cartridge in the insertion direction, and a pressing member having a first pressing portion configured to press the cartridge mounted on the mounting unit to separate the developing member from a photosensitive member. The pressing member has a second pressing portion configured to press the cartridge mounted on the mounting unit to bring the developing member into contact with the photosensitive member, and the first pressing portion and the second pressing portion integrally moves with the movement of the pressing member. The image forming apparatus also includes an elastic member configured to press the pressing member so that the second pressing portion presses the cartridge.

Abstract: A developing device includes a developing unit including a developer bearing member and a developing frame member configured to support the developer bearing member. The developing unit is supported to be pivotable about a first shaft and a second shaft. A biasing member configured to bias the first shaft is provided.

Abstract: An image forming apparatus adds heat and pressure to a toner image formed on a sheet, fixes the toner image to the sheet. The apparatus detects a temperature of an end of a fixing device, cools the end of the fixing device, controls a cooling level by a cooling device in accordance with the temperature, predicts a discharge amount of ultra fine particles based on a parameter depending on the cooling level, controls an image forming operation such that the discharge amount of ultra fine particles is reduced in accordance with the discharge amount predicted.

Abstract: Provided are: a transformation plasmid for transforming anaerobes and enabling highly efficient and stable secretory expression of a target protein; a gene delivery carrier formed from said anaerobes transformed by said plasmid; a pharmaceutical composition including said gene delivery carrier; and a method for diagnosing or treating an ischemic disease utilizing these. Also provided are: a novel secretory signal; a transformation plasmid including said secretory signal; a gene delivery carrier formed from anaerobes transformed by said plasmid; a pharmaceutical composition including said gene delivery carrier; and a method for diagnosing or treating an ischemic disease utilizing these.

Abstract: An image forming apparatus includes a mounting unit configured to mount a development unit including a developing member, a pressing member configured to press the development unit mounted on the mounting unit to separate the developing member from a photosensitive member or bring the developing member into contact with the photosensitive member, and an urging member configured to urge the pressing member, wherein, when mounting the development unit on the mounting unit, the development unit moves in a first direction from the pressing member toward the development unit, parallel to a direction in which the pressing member and the development unit are arranged side by side, wherein the pressing member is movable in the first direction, and wherein the urging member urges the pressing member to move the pressing member in the first direction.

Abstract: An image forming apparatus includes a mounting unit configured to mount a cartridge including a developing member by moving the cartridge in the insertion direction, and a pressing member having a first pressing portion configured to press the cartridge mounted on the mounting unit to separate the developing member from a photosensitive member. The pressing member has a second pressing portion configured to press the cartridge mounted on the mounting unit to bring the developing member into contact with the photosensitive member, and the first pressing portion and the second pressing portion integrally moves with the movement of the pressing member. The image forming apparatus also includes an elastic member configured to press the pressing member so that the second pressing portion presses the cartridge.

Abstract: An image forming apparatus includes a mounting unit configured to mount a development unit including a developing member, a pressing member configured to press the development unit mounted on the mounting unit to separate the developing member from a photosensitive member or bring the developing member into contact with the photosensitive member, and an urging member configured to urge the pressing member, wherein, when mounting the development unit on the mounting unit, the development unit moves in a first direction from the pressing member toward the development unit, parallel to a direction in which the pressing member and the development unit are arranged side by side, wherein the pressing member is movable in the first direction, and wherein the urging member urges the pressing member to move the pressing member in the first direction.

Abstract: A wireless communication technique in which information that has been encoded and interleaved (the sequence of bits has been rearranged) on the transmission side is subjected to iterative decoding processing by using a demodulator, a deinterleaver, a decoder, and an interleaver on the receiving side.

Abstract: An image forming apparatus includes a mounting unit configured to mount a cartridge including a developing member by moving the cartridge in the insertion direction, and a pressing member having a first pressing portion configured to press the cartridge mounted on the mounting unit to separate the developing member from a photosensitive member. The pressing member has a second pressing portion configured to press the cartridge mounted on the mounting unit to bring the developing member into contact with the photosensitive member, and the first pressing portion and the second pressing portion integrally moves with the movement of the pressing member. The image forming apparatus also includes an elastic member configured to press the pressing member so that the second pressing portion presses the cartridge.

Abstract: A wireless communication technique in which information that has been encoded and interleaved (the sequence of bits has been rearranged) on the transmission side is subjected to iterative decoding processing by using a demodulator, a deinterleaver, a decoder, and an interleaver on the receiving side.

Abstract: The endoscope includes an imaging device that is provided in a tip portion of an insertion part capable of being inserted into a body cavity. The imaging device includes an image sensor that photoelectrically converts imaging light incident on an image receiving surface thereof through an imaging lens provided in a lens barrel, and a circuit substrate including a connecting surface facing a terminal face that is a surface opposite to the image receiving surface of the image sensor. A plurality of terminals are uniformly arranged longitudinally and laterally in a two-dimensional matrix form on the terminal face of the image sensor, and the connecting surface of the circuit substrate and the terminal face of the image sensor are connected to each other through the plurality of terminals. The total area of the plurality of terminals on the terminal face occupies 10% or more of the area of an imaging area of the image receiving surface.

Abstract: A sheet detection unit includes a photo-interrupter, a shutter holder, and shutter members held to be movable relative to the shutter holder. The shutter members include a sheet rear end detection portion capable of switching an optical axis between a light-interrupted state and a light-transmitted state and each are supported to be movable to an abutment position where the shutter member causes an abutment surface to protrude, and also movable to a retracted position where the shutter member is retracted from a sheet conveyance path. Based on a detection signal output from the photo-interrupter by the sheet front end detection portion and the sheet rear end detection portion moving relative to the optical axis, a control unit determines the presence or absence of a sheet.

Abstract: To develop a conventional coupling for transmitting a driving force. A coupling member is provided with a supporting portion for movable supporting a driving force receiving portion for receiving a driving force.

Abstract: An image forming apparatus and a lock mechanism including a toggle mechanism capable of eliminating the problem of abnormal noise before and after a lock member passes a neutral point are provided. A lock mechanism includes a toggle spring that rotationally biases a toggle lever toward a standby position when the lever is between a standby position and a neutral point, and implements switching in a direction of the rotational biasing toward a locking position after the lever passes the neutral point. A projection and a locked portion of an engagement member are sandwiched by a toggle base and the toggle lever to maintain a contact state before and after the toggle lever passes the neutral point.

Abstract: The present invention provides the following: a cardiovascular disease primary prevention agent, which comprises as the active ingredient at least one selected from the group consisting of EPA, salts thereof, and esters thereof and is for lowering the risk of cardiovascular disease by administration to subjects having a blood (serum or plasma) hs-CRP level of 1.0 mg/L or higher in spite of no history of cardiovascular disease; a combination marker comprising the blood hs-CRP value and serum EPA/AA ratio for evaluating the primary risk of cardiovascular disease in subjects having no history of cardiovascular disease; and a method for extracting subjects with high risk of cardiovascular disease and/or a method for preventing cardiovascular disease.

Abstract: A developing device includes a developing unit including a developer bearing member and a developing frame member configured to support the developer bearing member. The developing unit is supported to be pivotable about a first shaft and a second shaft. A biasing member configured to bias the first shaft is provided.

Abstract: An image forming apparatus includes a mounting unit configured to mount a development unit including a developing member, a pressing member configured to press the development unit mounted on the mounting unit to separate the developing member from a photosensitive member or bring the developing member into contact with the photosensitive member, and an urging member configured to urge the pressing member, wherein, when mounting the development unit on the mounting unit, the development unit moves in a first direction from the pressing member toward the development unit, parallel to a direction in which the pressing member and the development unit are arranged side by side, wherein the pressing member is movable in the first direction, and wherein the urging member urges the pressing member to move the pressing member in the first direction.

Abstract: An image forming apparatus includes a mounting unit configured to mount a cartridge including a developing member by moving the cartridge in the insertion direction, and a pressing member having a first pressing portion configured to press the cartridge mounted on the mounting unit to separate the developing member from a photosensitive member. The pressing member has a second pressing portion configured to press the cartridge mounted on the mounting unit to bring the developing member into contact with the photosensitive member, and the first pressing portion and the second pressing portion integrally moves with the movement of the pressing member. The image forming apparatus also includes an elastic member configured to press the pressing member so that the second pressing portion presses the cartridge.

Abstract: The present invention provides the following: a cardiovascular disease primary prevention agent, which comprises as the active ingredient at least one selected from the group consisting of EPA, salts thereof, and esters thereof and is for lowering the risk of cardiovascular disease by administration to subjects having a blood (serum or plasma) hs-CRP level of 1.0 mg/L or higher in spite of no history of cardiovascular disease; a combination marker comprising the blood hs-CRP value and serum EPA/AA ratio for evaluating the primary risk of cardiovascular disease in subjects having no history of cardiovascular disease; and a method for extracting subjects with high risk of cardiovascular disease and/or a method for preventing cardiovascular disease.